142 related articles for article (PubMed ID: 33944672)
1. Urine metabolomic biomarkers for prediction of isolated fetal congenital heart defect.
Friedman P; Yilmaz A; Ugur Z; Jafar F; Whitten A; Ustun I; Turkoglu O; Graham S; Bahado Singh R
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6380-6387. PubMed ID: 33944672
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic prediction of fetal congenital heart defect in the first trimester.
Bahado-Singh RO; Ertl R; Mandal R; Bjorndahl TC; Syngelaki A; Han B; Dong E; Liu PB; Alpay-Savasan Z; Wishart DS; Nicolaides KH
Am J Obstet Gynecol; 2014 Sep; 211(3):240.e1-240.e14. PubMed ID: 24704061
[TBL] [Abstract][Full Text] [Related]
3. Targeted metabolomic analysis of plasma metabolites in patients with coronary heart disease in southern China.
Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Medicine (Baltimore); 2019 Feb; 98(7):e14309. PubMed ID: 30762730
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics.
Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B
J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476
[TBL] [Abstract][Full Text] [Related]
5. Study on the Potential Biomarkers of Maternal Urine Metabolomics for Fetus with Congenital Heart Diseases Based on Modified Gas Chromatograph-Mass Spectrometer.
Xie D; Luo Y; Xiong X; Lou M; Liu Z; Wang A; Xiong L; Kong F; Wang Y; Wang H
Biomed Res Int; 2019; 2019():1905416. PubMed ID: 31198782
[TBL] [Abstract][Full Text] [Related]
6. First-trimester metabolomic prediction of stillbirth.
Bahado-Singh RO; Syngelaki A; Mandal R; Han B; Li L; Bjorndahl TC; Wang N; Maulik D; Dong E; Turkoglu O; Tseng CL; Zeb A; Redman M; Wishart DS; Nicolaides KH
J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3435-3441. PubMed ID: 29712497
[No Abstract] [Full Text] [Related]
7. The value of lipid metabolites 9,10-DOA and 11,12-EET in prenatal diagnosis of fetal heart defects.
Fang Y; Zhang Z; Zhao Y; Sun G; Peng M; Liu C; Yi G; Zhao K; Yang H
Clin Chim Acta; 2023 Apr; 544():117330. PubMed ID: 37037297
[TBL] [Abstract][Full Text] [Related]
8. Maternal metabolomic profiling and congenital heart disease risk in offspring: A systematic review of observational studies.
Mires S; Reddy S; Skerritt C; Caputo M; Eastwood KA
Prenat Diagn; 2023 May; 43(5):647-660. PubMed ID: 36617630
[TBL] [Abstract][Full Text] [Related]
9. A prospective cohort study on association of first-trimester serum biomarkers and risk of isolated foetal congenital heart defects.
Hematian MN; Hessami K; Torabi S; Saleh M; Nouri B; Saleh M
Biomarkers; 2021 Dec; 26(8):747-751. PubMed ID: 34645361
[TBL] [Abstract][Full Text] [Related]
10. Maternal biomarkers for fetal heart failure in fetuses with congenital heart defects or arrhythmias.
Miyoshi T; Hosoda H; Nakai M; Nishimura K; Miyazato M; Kangawa K; Ikeda T; Yoshimatsu J; Minamino N
Am J Obstet Gynecol; 2019 Jan; 220(1):104.e1-104.e15. PubMed ID: 30273582
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics and first-trimester prediction of early-onset preeclampsia.
Bahado-Singh RO; Akolekar R; Mandal R; Dong E; Xia J; Kruger M; Wishart DS; Nicolaides K
J Matern Fetal Neonatal Med; 2012 Oct; 25(10):1840-7. PubMed ID: 22494326
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic prediction of severe maternal and newborn complications in preeclampsia.
Idler J; Turkoglu O; Yilmaz A; Ashrafi N; Szymanska M; Ustun I; Patek K; Whitten A; Graham SF; Bahado-Singh RO
Metabolomics; 2024 May; 20(3):56. PubMed ID: 38762675
[TBL] [Abstract][Full Text] [Related]
13. Associations between maternal genotypes and metabolites implicated in congenital heart defects.
Chowdhury S; Hobbs CA; MacLeod SL; Cleves MA; Melnyk S; James SJ; Hu P; Erickson SW
Mol Genet Metab; 2012 Nov; 107(3):596-604. PubMed ID: 23059056
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic identification of placental alterations in fetal growth restriction.
Bahado-Singh RO; Turkoglu O; Yilmaz A; Kumar P; Zeb A; Konda S; Sherman E; Kirma J; Allos M; Odibo A; Maulik D; Graham SF
J Matern Fetal Neonatal Med; 2022 Feb; 35(3):447-456. PubMed ID: 32041426
[TBL] [Abstract][Full Text] [Related]
15. Global metabolomic profiling reveals hepatic biosignatures that reflect the unique metabolic needs of late-term mother and fetus.
Saini N; Virdee M; Helfrich KK; Kwan STC; Smith SM
Metabolomics; 2021 Feb; 17(2):23. PubMed ID: 33550560
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for isolated congenital heart disease based on maternal amniotic fluid metabolomics analysis.
Yuan X; Li L; Kang H; Wang M; Zeng J; Lei Y; Li N; Yu P; Li X; Liu Z
BMC Cardiovasc Disord; 2022 Nov; 22(1):495. PubMed ID: 36404327
[TBL] [Abstract][Full Text] [Related]
17. [Importance of "Guidelines for performing fetal cardiac scan" in prenatal screening for fetal congenital heart disease].
Xu Y; Hu YL; Ru T; Gu Y; Yang Y; Dai CY
Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):103-7. PubMed ID: 19570419
[TBL] [Abstract][Full Text] [Related]
18. Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results.
Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
Am J Med Genet A; 2008 Oct; 146A(19):2455-67. PubMed ID: 18785270
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive screening for congenital heart defects using a serum metabolomics approach.
Troisi J; Cavallo P; Richards S; Symes S; Colucci A; Sarno L; Landolfi A; Scala G; Adair D; Ciccone C; Maruotti GM; Martinelli P; Guida M
Prenat Diagn; 2021 May; 41(6):743-753. PubMed ID: 33440021
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
